Previous 10 | Next 10 |
Inogen Announces Receipt of EU Quality Management Certification under the Medical Device Regulation for Portable Oxygen Concentrators Inogen Announces U.S. Food and Drug Administration 510(k) clearance for its Latest Portable Oxygen Concentrator Inogen to Launch New Rove Series Po...
Inogen to Present at J.P. Morgan Healthcare Conference This Week Inogen to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2022 Healthcare Conference on Tuesday, November 1...
Inogen, Inc. (INGN) Q3 2022 Results Conference Call November 02, 2022 08:00 AM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Mathew Blackman...
The following slide deck was published by Inogen, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Inogen, Inc. 2022 Q3 - Results - Earnings Call Presentation
Inogen press release ( NASDAQ: INGN ): Q3 Non-GAAP EPS of -$0.18 beats by $0.20 . Revenue of $105.39M (+13.2% Y/Y) beats by $7.67M . On a constant currency basis, total revenue for the period ended September 30, 2022, increased 14.5%. Cash and cash equivale...
Double Digit Year-over-Year Revenue Growth of 13.2% Constant Currency Year-over-Year Revenue Growth of 14.5% Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced fi...
Inogen ( NASDAQ: INGN ) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, before market open. The consensus EPS Estimate is -$0.38 and the consensus Revenue Estimate is $97.72M (+5.0% Y/Y). Over the last 1 year, INGN has beaten EPS estimates ...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022. On the same day, the Co...
Summary Inogen has been a long-term growth story which has seen real execution challenges in recent years. Current supply chain woes make up for a tough margin picture, yet operational issues have been seen for a couple of years now. Valuations are not too demanding, not in th...
News, Short Squeeze, Breakout and More Instantly...
2024-04-16 15:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024. On the same day, the Company will ho...
2024-03-27 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...